Joel Greenblatt Chemo Centryx, Inc. Transaction History

Gotham Asset Management, LLC

  • $10.2 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$32.73 - $50.78 $446,306 - $692,436
-13,636 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$6.81 - $39.55 $92,861 - $539,303
13,636 New
13,636 $539,000
Q3 2018

Nov 14, 2018
SELL
$10.49 - $13.72 $122,911 - $160,757
-11,717 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$10.62 - $13.98 $124,434 - $163,803
11,717 New
11,717 $154,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email